SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics is drawing intense community focus as investors weigh upcoming Phase 3 data catalysts for its lead psychiatric programs against concerns over cash burn and potential dilution. While some traders are bullish on the stock's clinical potential and institutional backing, others are actively debating management's track record and the long-term scalability of their psychedelic-based treatment models.

Zillow Group, Inc. engages in the provision of real estate and home-related information marketplaces on mobile and the web. The company was founded by Richard N. Barton and Lloyd D. Frink in December 2004 and is headquartered in Seattle, WA.

Zillow Group Inc - Ordinary Shares - Class C

Zillow Group Inc Class C

Zillow is trending as the community debates its technical performance and growth potential against a backdrop of ongoing antitrust litigation regarding its rental listing practices. Investors are actively discussing the company's valuation, potential upside from AI-driven integrations with ChatGPT, and its ability to maintain dominance in the housing sector amid regulatory scrutiny.

Liquidia Corp. operates as a holding company which engages through its subsidiary in developing and commercializing biopharmaceutical products and novel products development used in PRINT technology to transform the lives of patients. The company was founded in June 2004 and is headquartered in Morrisville, NC.

Liquidia Corp

Liquidia is currently trending as investors monitor rapid Yutrepia product adoption and positive sales growth, while the community closely debates the potential impact of ongoing patent litigation and M&A speculation. Shareholders are largely focused on the company's competitive position against market peers and the anticipation of a pivotal legal ruling that could significantly shift the stock's valuation.

PENGU is the official coin of Pudgy Penguins.  Pudgy Penguins has become the face of crypto with one of the most influential communities in the industry. From large companies wearing the Penguin, to being featured in ETF commercials, to garnering millions of followers and over 100 billion views, the Pengu has become a cultural icon making PENGU the world’s social currency.  PENGU allows for the ever-expanding Pudgy Penguin fanbase and the hundreds of millions of people outside of crypto that see and share the Pudgy Penguin everyday, to join The Huddle. PENGU is a symbol for community, memes, and good vibes.  Believe in Pengu. Believe in the Prophecy.

Pudgy Penguins

Pudgy Penguins is trending as investors debate its long-term potential, with bulls pointing to the brand's expanding real-world retail footprint and unique IP partnerships as reasons for optimism. While some community members remain frustrated by stagnant price action compared to the broader crypto market, others are actively accumulating tokens, betting that its utility and mainstream cultural reach will drive significant future gains.

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders such as Parkinson’s disease, metabolic disorders, including thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Abbvie Inc

AbbVie is trending as investors monitor its pipeline and strategic moves in the obesity and immunology sectors, while the community heavily debates potential M&A activity involving the company and clinical-stage assets. Traders are actively discussing technical support levels and volume patterns alongside ongoing speculation about the company's competitive positioning against other major pharmaceutical firms.

Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Trulieve Cannabis Corp 

Trulieve Cannabis Corp is currently trending as the first major U.S. cannabis company to uplist to the NYSE, a milestone that has triggered intense discussion regarding institutional liquidity and potential regulatory shifts. The community is actively debating the company's valuation and strategic direction following the recent departure of a top executive, while closely monitoring market volatility related to broader sector index rebalancing.

Fiserv, Inc. engages in the provision of financial services technology. It operates through the Merchant and Financial segments. The Merchant segment offers commerce-enabling products and services including merchant acquiring and digital commerce and mobile payment services, and security and fraud protection, stored-value, and pay-by-bank solutions to companies of all sizes. The Financial segment provides products and services such as processing of customer loan and deposit accounts, digital payments, and card transactions to financial institutions and corporate and public sector clients. The company was founded by Leslie M. Muma and George D. Dalton on July 31, 1984 and is headquartered in Milwaukee, WI.

Fiserv, Inc.

Fiserv is currently a focal point for investors debating whether its deeply depressed valuation at low forward price-to-earnings multiples represents a historic buying opportunity or a structural value trap in the face of legacy fintech disruption. While some market participants are aggressively accumulating shares and citing institutional backing, others are actively dumping the stock due to stalled revenue growth, high debt levels, and frustration over the company's long-term performance.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera Biologics is currently a major focus for traders as they anticipate the upcoming Q1 earnings report and critical interim Phase 1 clinical data for its lead candidate, ABCL635. While the community is actively debating the stock's long-term potential versus its history of underperformance, strong institutional accumulation and notable analyst upgrades are driving significant volume and heightened short-interest volatility.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

Hedera Hashgraph is trending as investors debate its long-term enterprise utility and corporate governing council structure against ongoing concerns regarding token supply dilution. The community remains deeply divided, with some actively accumulating at current levels in anticipation of regulatory developments and institutional adoption, while others express frustration over stagnant price action.

Tidal Trust II - YieldMax Ultra Option Income Strategy ETF

YieldMax Ultra Option Income Strategy ETF

ULTY is trending due to investor discourse surrounding the fund's recent 1-for-10 reverse stock split and a strategic shift in holdings toward large-cap blue chips to combat ongoing NAV erosion. The community remains deeply divided, with some investors focusing on high yield and potential recovery, while others criticize the fund's performance and payout volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

VIV Makes Notable Cross Below Critical Moving Average

In trading on Friday, shares of Telefonica Brasil SA (Symbol: VIV) crossed below their 200 day moving average of $13.72, changing hands as low as $13.24 per share. Telefonica Brasil SA shares are currently trading off about 5% on the day. The chart below shows the one year per...

VIV vs. SCMWY: Which Stock Should Value Investors Buy Now?

VIV vs. SCMWY: Which Stock Is the Better Value Option?

1Q26 Results: Telefnica Brasil S.A.

1Q26 Results: Telefnica Brasil S.A. 1Q26 Results: Telefnica Brasil S.A. PR Newswire SO PAULO, May 11, 2026 Telefnica Brasil - (B3: VIVT3; NYSE: VIV) announces its results for 1Q26.SO PAULO, May 11...

Strs Ohio Sells 124,891 Shares of Telefonica Brasil S.A. $VIV

Strs Ohio decreased its position in Telefonica Brasil S.A. (NYSE:VIV - Free Report) by 14.9% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 715,109 shares of the Wireless communications provider's stock after selling 124,891 shares dur...

Telefonica Brasil (VIV) Expected to Announce Quarterly Earnings on Monday

Telefonica Brasil (NYSE:VIV) will be releasing its Q1 2026 earnings after the market closes on Monday, May 11. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-11-telefnica-brasil-sa-stock...

Telefonica Brasil (NYSE:VIV) Stock Price Passes Above 200 Day Moving Average - Time to Sell?

Telefonica Brasil (NYSE:VIV) Shares Pass Above Two Hundred Day Moving Average - What's Next...

Is Koninklijke KPN (KKPNF) Outperforming Other Utilities Stocks This Year?

Here is how Koninklijke KPN NV (KKPNF) and Telefonica Brasil (VIV) have performed compared to their sector so far this year.

Here's Why Telefonica Brasil (VIV) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Telefonica Brasil S.A. (NYSE:VIV) Receives Average Recommendation of "Hold" from Analysts

Shares of Telefonica Brasil S.A. (NYSE:VIV - Get Free Report) have earned an average rating of "Hold" from the ten analysts that are covering the stock, MarketBeat Ratings reports. Three analysts...

Zacks.com featured highlights include Repsol, TechnipFMC, Telefonica Brasil and USA Compression

Repsol leads a group of high-efficiency stocks outperforming peers on profitability, with strong earnings surprises signaling solid operational performance.

Telefonica Brasil SA engages in the provision of telecommunication services. It offers post paid mobile and fixed telecommunications services, such as fixed and mobile voice, fixed, mobile broadband and ultra broadband. The company was founded in May 1998 and is headquartered in Sao Paulo, Brazil.

Current Price	$13.36
Prev Close	$13.17
Open	$13.30
Dividend Yield	2.99%
50-Day Moving Average	$14.90
Beta	0.47
Avg. Volume	1.15M
PE Ratio	18.30

52-Week High	$17.26
52-Week Low	$10.73
Market Capitalization	$21.35B
EPS (Annual)	$0.685
Price to Book	1.60
Revenue Per Employee	N/A

VIVVivo Participacoes S.A.

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest VIV News